{"id":13660,"date":"2025-06-05T09:42:29","date_gmt":"2025-06-05T09:42:29","guid":{"rendered":"https:\/\/www.eurobio-scientific.com\/?post_type=press-releases&#038;p=13660"},"modified":"2025-06-25T15:28:43","modified_gmt":"2025-06-25T15:28:43","slug":"half-year-financial-report-available","status":"publish","type":"press-releases","link":"https:\/\/www.eurobio-scientific.com\/fr\/press-releases\/half-year-financial-report-available\/","title":{"rendered":"Rapport financier semestriel disponible"},"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"press":[278],"class_list":["post-13660","press-releases","type-press-releases","status-publish","hentry","press-278"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Half-year financial report available | Eurobio-Scientific<\/title>\n<meta name=\"description\" content=\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation &amp; oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/half-year-financial-report-available\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Half-year financial report available\" \/>\n<meta property=\"og:description\" content=\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation &amp; oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/half-year-financial-report-available\/\" \/>\n<meta property=\"og:site_name\" content=\"Eurobio-Scientific\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-25T15:28:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/half-year-financial-report-available\\\/\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/half-year-financial-report-available\\\/\",\"name\":\"Half-year financial report available | Eurobio-Scientific\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#website\"},\"datePublished\":\"2025-06-05T09:42:29+00:00\",\"dateModified\":\"2025-06-25T15:28:43+00:00\",\"description\":\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation & oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/half-year-financial-report-available\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/half-year-financial-report-available\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/half-year-financial-report-available\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Half-year financial report available\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#website\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/\",\"name\":\"eurobio-scientific.com\",\"description\":\"Experts in diagnostic solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#organization\"},\"alternateName\":\"eurobio-scientific.fr\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#organization\",\"name\":\"Eurobio Scientific\",\"alternateName\":\"Eurobio Scientific\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png\",\"contentUrl\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png\",\"width\":612,\"height\":204,\"caption\":\"Eurobio Scientific\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/eurobio-scientific\\\/\"],\"description\":\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation & oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions\",\"email\":\"contact@eurobio-scientific.com\",\"telephone\":\"+33 169796480\",\"legalName\":\"Eurobio Scientific\",\"foundingDate\":\"1962-02-14\",\"vatID\":\"TVAFR414488171\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"},\"actionableFeedbackPolicy\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/privacy-policy\\\/\",\"correctionsPolicy\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/privacy-policy\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Half-year financial report available | Eurobio-Scientific","description":"Le groupe Eurobio Scientific est \u00e0 la pointe de l'innovation dans les domaines des maladies infectieuses, de la transplantation et de l'oncologie en d\u00e9veloppant et en soutenant un portefeuille complet de technologies de diagnostic mol\u00e9culaire comprenant nos propres solutions et celles de nos partenaires.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/half-year-financial-report-available\/","og_locale":"fr_FR","og_type":"article","og_title":"Half-year financial report available","og_description":"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation & oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.","og_url":"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/half-year-financial-report-available\/","og_site_name":"Eurobio-Scientific","article_modified_time":"2025-06-25T15:28:43+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.eurobio-scientific.com\/press-releases\/half-year-financial-report-available\/","url":"https:\/\/www.eurobio-scientific.com\/press-releases\/half-year-financial-report-available\/","name":"Half-year financial report available | Eurobio-Scientific","isPartOf":{"@id":"https:\/\/www.eurobio-scientific.com\/#website"},"datePublished":"2025-06-05T09:42:29+00:00","dateModified":"2025-06-25T15:28:43+00:00","description":"Le groupe Eurobio Scientific est \u00e0 la pointe de l'innovation dans les domaines des maladies infectieuses, de la transplantation et de l'oncologie en d\u00e9veloppant et en soutenant un portefeuille complet de technologies de diagnostic mol\u00e9culaire comprenant nos propres solutions et celles de nos partenaires.","breadcrumb":{"@id":"https:\/\/www.eurobio-scientific.com\/press-releases\/half-year-financial-report-available\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurobio-scientific.com\/press-releases\/half-year-financial-report-available\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurobio-scientific.com\/press-releases\/half-year-financial-report-available\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurobio-scientific.com\/"},{"@type":"ListItem","position":2,"name":"Half-year financial report available"}]},{"@type":"WebSite","@id":"https:\/\/www.eurobio-scientific.com\/#website","url":"https:\/\/www.eurobio-scientific.com\/","name":"eurobio-scientific.com","description":"Eurobio Scientific I Experts en solutions de diagnostic","publisher":{"@id":"https:\/\/www.eurobio-scientific.com\/#organization"},"alternateName":"eurobio-scientific.fr","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurobio-scientific.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.eurobio-scientific.com\/#organization","name":"Eurobio Scientific","alternateName":"Eurobio Scientific","url":"https:\/\/www.eurobio-scientific.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.eurobio-scientific.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.eurobio-scientific.com\/wp-content\/uploads\/2024\/09\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png","contentUrl":"https:\/\/www.eurobio-scientific.com\/wp-content\/uploads\/2024\/09\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png","width":612,"height":204,"caption":"Eurobio Scientific"},"image":{"@id":"https:\/\/www.eurobio-scientific.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/eurobio-scientific\/"],"description":"Le groupe Eurobio Scientific est \u00e0 la pointe de l'innovation dans les domaines des maladies infectieuses, de la transplantation et de l'oncologie en d\u00e9veloppant et en soutenant un portefeuille complet de technologies de diagnostic mol\u00e9culaire comprenant nos propres solutions.","email":"contact@eurobio-scientific.com","telephone":"+33 169796480","legalName":"Eurobio Scientific","foundingDate":"1962-02-14","vatID":"TVAFR414488171","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"},"actionableFeedbackPolicy":"https:\/\/www.eurobio-scientific.com\/privacy-policy\/","correctionsPolicy":"https:\/\/www.eurobio-scientific.com\/privacy-policy\/"}]}},"_links":{"self":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press-releases\/13660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press-releases"}],"about":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/types\/press-releases"}],"version-history":[{"count":0,"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press-releases\/13660\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/media?parent=13660"}],"wp:term":[{"taxonomy":"press","embeddable":true,"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press?post=13660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}